REDX — Redx Pharma Share News
0.000.00%
Last trade - 00:00- £35.01m
- £34.60m
- £4.20m
Press Digest: British Business - Feb 24
Jounce Therapeutics jumps on merger deal with Redx Pharma
Biotech firms Redx Pharma and Jounce Therapeutics to merge in $425 mln deal (updated)
Brief: Jounce Therapeutics & Redx Pharma Agree to Merge
Brief: Redx And Jounce Announce Recommended Business Combination
Biotech firms Redx Pharma and Jounce Therapeutics to combine business
Notice of AGM
Brief: Redx Pharma Says Recruiting Patients Across Five European Countries For RXC007 Clinical Programme
Progress Update on RXC007 Clinical Programme
Redx to Present at Wnt & ß-Catenin Pathway Summit
New Grant of Options
Final Results for the Year Ended 30 September 2022
UK's Redx Pharma rises 6% on Merck deal
Brief: Redx Pharma Signs Clinical Trial Agreement With MSD
Clinical Trial Agreement with MSD
Notice of Preliminary Results
Redx to Present Poster at IBD Nordic Conference
Brief: Redx Pharma Says Ongoing Phase 2 Clinical Studies Of RXC004 Will Open Enrolment Into Combination Arms
RXC004 Phase 2 Combination Arms to Open Enrolment